$NNE
Nano Nuclear Energy Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224024530 Filed on June 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.301M $1.423M $828.9K
YoY Change -38.14%
% of Gross Profit
Research & Development $2.020M $290.5K $520.0K
YoY Change 70.63% -26.05%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.707M $1.714M $1.349M
YoY Change -4.03% 12.72%
Operating Profit
YoY Change
Interest Expense $36.22K $34.97K
YoY Change
% of Operating Profit
Other Income/Expense, Net $38.37K
YoY Change
Pretax Income -$4.668M -$1.678M -$1.314M
YoY Change -4.81%
Income Tax
% Of Pretax Income
Net Earnings -$4.668M -$1.678M -$1.314M
YoY Change -4.81% 10.34%
Net Earnings / Revenue
Basic Earnings Per Share -$0.17 -$0.07
Diluted Earnings Per Share -$0.17 -$0.07 -$0.05
COMMON SHARES
Basic Shares Outstanding 28.57M shares 23.86M shares
Diluted Shares Outstanding 27.73M shares 23.86M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.955M $7.898M
YoY Change
Cash & Equivalents $13.79M $5.955M
Short-Term Investments
Other Short-Term Assets $635.0K $217.0K
YoY Change
Inventory
Prepaid Expenses $530.2K $635.0K
Receivables
Other Receivables
Total Short-Term Assets $14.32M $6.590M $8.114M
YoY Change 71.3%
LONG-TERM ASSETS
Property, Plant & Equipment $1.915M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $235.2K
YoY Change
Other Assets $130.0K $130.0K
YoY Change
Total Long-Term Assets $2.108M $2.280M $130.0K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $14.32M $6.590M $8.114M
Total Long-Term Assets $2.108M $2.280M $130.0K
Total Assets $16.43M $8.870M $8.244M
YoY Change 96.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $299.5K $398.3K
YoY Change
Accrued Expenses $281.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.806M $605.5K $443.3K
YoY Change 557.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.629M
YoY Change
Total Long-Term Liabilities $1.629M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.806M $605.5K $443.3K
Total Long-Term Liabilities $1.629M $0.00
Total Liabilities $3.424M $2.234M $443.3K
YoY Change 1146.14%
SHAREHOLDERS EQUITY
Retained Earnings -$14.94M -$10.27M
YoY Change
Common Stock $2.900K $2.601K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.00M $6.636M $2.801M
YoY Change
Total Liabilities & Shareholders Equity $16.43M $8.870M $8.244M
YoY Change 96.51%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$4.668M -$1.678M -$1.314M
YoY Change -4.81% 10.34%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.545M -$2.302M -$1.107M
YoY Change -8.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.38M 360.0K 2.051M
YoY Change 18.41%
NET CHANGE
Cash From Operating Activities -2.545M -2.302M -1.107M
Cash From Investing Activities
Cash From Financing Activities 10.38M 360.0K 2.051M
Net Change In Cash 7.834M -1.942M 944.7K
YoY Change 30.61%
FREE CASH FLOW
Cash From Operating Activities -$2.545M -$2.302M -$1.107M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001923891
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
shares
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
shares
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
NNE Conversion From Mezzanine Equity To Stockholders Equity
ConversionFromMezzanineEquityToStockholdersEquity
usd
NNE Inception Of Right Of Use Asset Liability
InceptionOfRightOfUseAssetLiability
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
NNE Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
usd
us-gaap Operating Lease Cost
OperatingLeaseCost
usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
usd
us-gaap Operating Lease Payments
OperatingLeasePayments
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-42044
dei Entity Registrant Name
EntityRegistrantName
Nano Nuclear Energy, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0861977
dei Entity Address Address Line1
EntityAddressAddressLine1
10 Times Square
dei Entity Address Address Line2
EntityAddressAddressLine2
30th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
634-9206
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
NNE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28569513 shares
CY2024Q1 us-gaap Cash
Cash
5955028 usd
CY2023Q3 us-gaap Cash
Cash
6952795 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
205857 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
7158652 usd
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
75000 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
235235 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1914778 usd
CY2023Q3 us-gaap Assets
Assets
7233652 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
190005 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
280951 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
605459 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
225005 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1628591 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2234050 usd
CY2023Q3 us-gaap Liabilities
Liabilities
225005 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2000000 shares
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5000000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26007013 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23184869 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2000000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
2601 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2319 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16907165 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9288553 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10273798 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7282225 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6635968 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2008647 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8870018 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7233652 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1423309 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1127534 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2252205 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1683973 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
290539 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
392900 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
810555 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
520606 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1713848 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1520434 usd
us-gaap Operating Expenses
OperatingExpenses
3062760 usd
us-gaap Operating Expenses
OperatingExpenses
2204579 usd
CY2024Q1 us-gaap Other Income
OtherIncome
36220 usd
us-gaap Other Income
OtherIncome
71187 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1677628 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1520434 usd
us-gaap Net Income Loss
NetIncomeLoss
-2991573 usd
us-gaap Net Income Loss
NetIncomeLoss
-2204579 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23861244 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22307508 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23521208 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21747734 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23861244 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22307508 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23521208 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21747734 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2000000 shares
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2801139 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
360000 usd
CY2024Q1 NNE Temporary Equity Shares Mezzanine Equity Conversion
TemporaryEquitySharesMezzanineEquityConversion
-2000000 shares
CY2024Q1 NNE Temporary Equity Value Mezzanine Equity Conversion
TemporaryEquityValueMezzanineEquityConversion
-5000000 usd
CY2024Q1 NNE Stock Issued During Period Value Mezzanine Equity Conversion
StockIssuedDuringPeriodValueMezzanineEquityConversion
5000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
152457 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1677628 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6635968 usd
CY2023Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2000000 shares
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2008647 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2466437 usd
NNE Temporary Equity Shares Mezzanine Equity Conversion
TemporaryEquitySharesMezzanineEquityConversion
-2000000 shares
NNE Temporary Equity Value Mezzanine Equity Conversion
TemporaryEquityValueMezzanineEquityConversion
-5000000 usd
NNE Stock Issued During Period Value Mezzanine Equity Conversion
StockIssuedDuringPeriodValueMezzanineEquityConversion
5000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
152457 usd
us-gaap Net Income Loss
NetIncomeLoss
-2991573 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6635968 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3023400 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
307500 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
584484 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1520434 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2394950 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2109676 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2109676 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1820369 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
669484 usd
us-gaap Net Income Loss
NetIncomeLoss
-2204579 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2394950 usd
us-gaap Net Income Loss
NetIncomeLoss
-2991573 usd
us-gaap Net Income Loss
NetIncomeLoss
-2204579 usd
us-gaap Share Based Compensation
ShareBasedCompensation
152457 usd
us-gaap Share Based Compensation
ShareBasedCompensation
669484 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11878 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
55000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3409204 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1469139 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2466437 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1820369 usd
NNE Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
55000 usd
NNE Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2411437 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1770369 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-997767 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
301230 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6952795 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2129999 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5955028 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2431229 usd
NNE Conversion From Mezzanine Equity To Stockholders Equity
ConversionFromMezzanineEquityToStockholdersEquity
-5000000 usd
NNE Inception Of Right Of Use Asset Liability
InceptionOfRightOfUseAssetLiability
1926656 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 NNE Working Capital
WorkingCapital
5984546 usd
us-gaap Net Income Loss
NetIncomeLoss
-2991573 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10273798 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3409204 usd
CY2023Q3 NNE Working Capital
WorkingCapital
6933647 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6250401 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7282225 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3867573 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zsSiikxFUZ03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_860_zSl6xvBdDgRc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated interim financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions made when accounting for items and matters such as, but not limited to, equity-based compensation and contingencies are reasonable, based on information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the condensed consolidated interim financial statements, as well as amounts reported on the statements of operations during the periods presented. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zidjKThBIeqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_86C_zTBEqZYimGR4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances at a financial institution and such amounts exceeded federally insured limits at March 31, 2024 and September 30, 2023. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Advertising Expense
AdvertisingExpense
608600 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
159200 usd
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
434800 usd
us-gaap Advertising Expense
AdvertisingExpense
177600 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2599000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1971000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
125000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.00
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
36220 usd
us-gaap Interest Income Other
InterestIncomeOther
71187 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Common Stock are entitled to one vote per share
CY2023Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2000000 shares
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
2.50
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0437 pure
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y6M
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.825 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.22
CY2024Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.57
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4007000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.23
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M14D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2004000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
125000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.00
NNE Sharebased Compensation Arrangement By Sharebased Payment Options Granted Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentOptionsGrantedOutstandingWeightedAverageRemainingContractualTerm2
P2Y11M15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
152000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4132000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.23
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M14D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2156000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y11M15D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
152000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4132000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y25D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2156000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1914778 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
280951 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1628591 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
28369 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
28369 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
33605 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
33605 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.135 pure
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M18D
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
100815 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
339411 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
418508 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
428971 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
439695 usd
CY2024Q1 NNE Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1306255 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3033655 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1124113 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1909542 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
280951 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1628591 usd

Files In Submission

Name View Source Status
0001493152-24-024530-index-headers.html Edgar Link pending
0001493152-24-024530-index.html Edgar Link pending
0001493152-24-024530.txt Edgar Link pending
0001493152-24-024530-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nne-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nne-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nne-20240331_cal.xml Edgar Link unprocessable
nne-20240331_def.xml Edgar Link unprocessable
nne-20240331_lab.xml Edgar Link unprocessable